CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway. - Test2 - elhamkhani - TriplyDB

CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway.

CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway.

http://www.wikidata.org/entity/Q34018947

about

Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complex Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level Tumor-specific activation of the C-JUN/MELK pathway regulates glioma stem cell growth in a p53-dependent manner.Suppression of peroxiredoxin 4 in glioblastoma cells increases apoptosis and reduces tumor growth.The significance of Notch1 compared with Notch3 in high metastasis and poor overall survival in hepatocellular carcinoma.Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression.Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.CD44: molecular interactions, signaling and functions in the nervous system Arsenic trioxide sensitizes glioblastoma to a myc inhibitor.Expression of CD44v6 and Its Association with Prognosis in Epithelial Ovarian Carcinomas.Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells.Nomogram Incorporating CD44v6 and Clinicopathological Factors to Predict Lymph Node Metastasis for Early Gastric Cancer Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine.Common polymorphisms in CD44 gene and susceptibility to cancer: A systematic review and meta-analysis of 45 studies.In situ identification of CD44+/CD24- cancer cells in primary human breast carcinomas.CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas.Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.Proteoglycans and their roles in brain cancer.Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.The prognostic significance of CD44V6, CDH11, and β-catenin expression in patients with osteosarcoma MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells.CD44 receptor unfolding enhances binding by freeing basic amino acids to contact carbohydrate ligand.Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor.CD44v6-Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells.CD44 regulation of endothelial cell proliferation and apoptosis via modulation of CD31 and VE-cadherin expression.Expression and association of CD44v6 with prognosis in T2-3N0M0 esophageal squamous cell carcinoma.Cancer stem cells, microRNAs, and therapeutic strategies including natural products.CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.Osteopontin as a therapeutic target for cancer.Detoxification of oxidative stress in glioma stem cells: mechanism, clinical relevance, and therapeutic development.Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo.Adhering towards tumorigenicity: altered adhesion mechanisms in glioblastoma cancer stem cells.

P2860

Q24306474-356DF4B2-C779-4E39-B65F-3FA1A3AC5016 Q26772180-98D2F144-BEBB-4296-8745-5C345FF54FE6 Q28084610-CCDDAACC-D8AA-483B-982D-6A1651471E7F Q33779328-F7397674-3E61-4552-9105-7362670A9869 Q33874532-56B114D1-D9A3-49F7-ABDE-488C67ED59CF Q34044078-15F58B68-E08B-4DA2-8959-106209FE6000 Q34391054-6FFF91E4-A999-468F-A9D1-7BCA8BF5C9E9 Q34612059-B60A15AD-67AC-4C95-8F7D-12C06A38AB46 Q34973811-0EAF7BB7-225C-4A68-93D5-8147BF528A27 Q35022551-4A947C77-C7BE-44CC-9055-0514DCC40BF8 Q35116847-24EC7BC4-0D2E-49F4-B55F-AE9E4AD121E1 Q35554585-AAF86D8F-E35B-464F-9414-07913BD04A70 Q35573268-77F38BF0-9C9C-4EC9-8DE3-44CBD1052EC0 Q35580052-425F71FA-6595-4721-B9BC-5F345A4A456D Q35650870-544FA1A5-47AD-4D4D-8DFB-F3C241C7F0EE Q35864434-3B958615-7273-4D5B-AF6A-5DC2B78125F4 Q35911598-6388F548-7C73-44B6-A316-7B95B80253FA Q36092350-4FEBC07C-55F9-4BC2-9763-A779C39B5813 Q36156256-0ADE5457-186B-42E8-B2BF-C5AD20B6CC2B Q36163284-CD8D6472-C97F-43F2-A9CA-DD6E12692ABA Q36232533-35D1DA62-2004-4920-B80C-B713FAB1ACE4 Q36262890-02E91D96-A99E-4AAC-A6CE-7E095CAD5574 Q36413567-E94D57C0-64E7-4B92-ABD8-20B202F14EA2 Q36579481-7B4F5AD0-3EC5-459F-8E2F-36843483EF75 Q36816444-36C101BD-9B6C-4A32-A263-01C48DA259CC Q36991152-BB1C6D86-D6FC-4CEA-A38B-E43621572D2B Q37067646-165877E0-026C-44BC-A2F2-DF8C28D7FAF2 Q37098261-5D10F18C-FB96-454B-AF38-2AC192658303 Q37145661-3FAD594B-51E4-4065-8B65-ABA879A9BC31 Q37279893-87242F86-B6CF-4B62-B336-E539537D8F4E Q37507256-DD5A614D-8374-408B-8B31-F2BE7DE4E724 Q37588008-0B812682-F5B1-4D53-AD36-3B47786C5901 Q37608401-634E1662-F2DD-4EFF-A82A-88909B451568 Q37620510-13DB4F1F-359F-457F-831F-B7D46A70E2D5 Q38023238-740F27E6-AB23-4CC0-AC20-6B9687EE2D7F Q38100108-A08D1FC1-B444-4686-9A4E-E8B7DC251CE7 Q38217758-4DC9DBAF-B81A-482F-8D1A-C8C664A83DAB Q38231884-8E2E569F-14FE-4198-892A-9327C28A5BA0 Q38916554-96C24569-B243-47CD-A669-AF6D8E5DBC38 Q38951345-EF443E42-C02F-45CC-B42F-E6A296743908

P2860

CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway.

http://www.wikidata.org/entity/Q34018947

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

CD44v6 regulates growth of bra ...... ough the AKT-mediated pathway.

@ast

CD44v6 regulates growth of bra ...... ough the AKT-mediated pathway.

@en

CD44v6 regulates growth of bra ...... ough the AKT-mediated pathway.

@nl

type

label

CD44v6 regulates growth of bra ...... ough the AKT-mediated pathway.

@ast

CD44v6 regulates growth of bra ...... ough the AKT-mediated pathway.

@en

CD44v6 regulates growth of bra ...... ough the AKT-mediated pathway.

@nl

prefLabel

CD44v6 regulates growth of bra ...... ough the AKT-mediated pathway.

@ast

CD44v6 regulates growth of bra ...... ough the AKT-mediated pathway.

@en

CD44v6 regulates growth of bra ...... ough the AKT-mediated pathway.

@nl

P1433

Q34018947-53071BCA-C6B9-4B76-94BB-CFBA2617DBC8

P1476

Q34018947-132F54B0-3D01-4729-9954-71160055F7DA

P2093

Q34018947-0198AF94-01DD-41C9-867C-85802EDB4D81

Q34018947-10A239E1-EA89-45BF-B6FA-EE0C3B8466AF

Q34018947-11A42D8B-0978-4721-BF91-A2B2F0D5366C

Q34018947-1245B196-FF04-4A30-8317-74B16CF5ECF3

Q34018947-21759B0A-981B-4A55-B8D6-8908CC012DCF

Q34018947-2660E132-39CF-4486-BE36-54E9E9E79229

Q34018947-28A6DE02-0CE5-4D8F-8695-8B68DAD97BE6

Q34018947-65BC6A67-EE2F-4A80-A218-12E88BBF1359

Q34018947-6B2D91A4-280D-4C50-93BB-D129930B1C2C

Q34018947-7F9889D3-0028-4650-8801-3341569E08F1

P2860

Q34018947-01D51D2F-1903-4D86-914F-C6B759F55F82

Q34018947-04DFCDFA-32C8-444E-B33B-07CC67B1C8E2

Q34018947-08CBA594-0EF8-4B0A-8C18-0E7DE9695B03

Q34018947-0B142010-6D7D-48C3-99B6-4A57241AAD94

Q34018947-168865E9-0BB0-4C55-A40D-B1FE91D53D1B

Q34018947-174CCE34-4EB0-4ED2-90CF-79D8E0A6B4DE

Q34018947-194398ED-4CF2-45B5-B260-FB28A986F7CF

Q34018947-1C05FDD9-3D38-47C6-95BF-32FD5B16EEC4

Q34018947-1DB6403A-7B77-4FD3-8AD4-54A8BEC96D78

Q34018947-2237D435-3C74-4C6F-BB5D-8D21BB5B17B4

P304

Q34018947-943716DA-77FD-4406-9041-B7726CBEC7C0

P31

Q34018947-64F26A72-E1C0-4B84-B23C-268E13B172B3

P356

Q34018947-52E32714-57D5-4F6F-AC19-5FF23653F49A

P407

Q34018947-08B855C2-7A9D-4D0B-9263-9C4B741CE76A

P433

Q34018947-94D4AE08-8BDF-467D-A6BE-A8261AD63C38

P478

Q34018947-E5939C0B-A9CD-4A8F-9ACF-544B222DED88

P577

Q34018947-F4FA07E2-3312-4337-BDB9-BEE29D452B25

P5875

Q34018947-C7AC6BAE-C75D-4CF6-8306-5E194C3CFB89

P698

Q34018947-2AB7596D-6E98-402F-A92E-F36F994A8B86

P932

Q34018947-9DCAAC18-FBF0-4489-B487-881397220DD9

P356

JOURNAL.PONE.0024217

P1433

P1476

CD44v6 regulates growth of bra ...... ough the AKT-mediated pathway.

@en

P2093

Crystal Leung

http://www.w3.org/2001/XMLSchema#string

Habibe Demir

http://www.w3.org/2001/XMLSchema#string

Harley I Kornblum

http://www.w3.org/2001/XMLSchema#string

Ichiro Nakano

http://www.w3.org/2001/XMLSchema#string

Ichiyo Shibahara

http://www.w3.org/2001/XMLSchema#string

Jason A de Jesus

http://www.w3.org/2001/XMLSchema#string

Kaushal Joshi

http://www.w3.org/2001/XMLSchema#string

Mayumi Jijiwa

http://www.w3.org/2001/XMLSchema#string

Nicholas Orozco

http://www.w3.org/2001/XMLSchema#string

Paul S Mischel

http://www.w3.org/2001/XMLSchema#string

P2860

CD44 cell adhesion molecules

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Identification of human brain tumour initiating cells

Identification of a cancer stem cell in human brain tumors

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

Cancer stem cells: Invitation to a second round

TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma

Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells.

P304

e24217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0024217

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51641532

http://www.w3.org/2001/XMLSchema#string

P698

21915300

http://www.w3.org/2001/XMLSchema#string

P932

3167830

http://www.w3.org/2001/XMLSchema#string